Special Series

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Call for Papers: “Radiation Oncology in 2026” Special Series
Call for Papers: “How We Treat Lung Cancer in 2026” Special Series
Call for Papers: Special Series on Pediatric CNS Tumors in 2026
Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Call for Papers: Special Series on Cancer in the Middle East in 2026
Call for Papers: Special Series on Cancer in Central Asia in 2026
Call for Papers: Special Series on Colorectal Cancer in 2026
Call for Papers: Special Series on Gastrointestinal Oncology in 2026
Call for Papers: Special Series on Pediatric Cancer in Africa in 2026
Call for Papers: Special Series on Cancer in Latin America in 2026